Effect of Artificial Tears on Biometry
Primary Purpose
Cataract
Status
Withdrawn
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Systane Complete
Sponsored by
About this trial
This is an interventional treatment trial for Cataract focused on measuring biometry measurement, artificial tear, cataract surgery
Eligibility Criteria
Inclusion Criteria:
- Male or female ≥ 18 years of age
- Documentation of bilateral age-related senile cataracts diagnosis
Exclusion Criteria:
- Patients currently using regularly scheduled artificial tears. Patients with infrequent or irregular use of artificial tears may not be excluded from the study.
- Patients using contact lenses.
- Patients with any other surface pathology affecting corneal biometric measurements determined with slit-lamp examination or medical history.
Sites / Locations
- Weill Cornell Ophthalmology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Artificial Tears
No Artificial Tears
Arm Description
One eye of each participant is randomized to receive Systane Complete artificial tears 4 times a day for 14 days
One eye of each participant is randomized to receive no artificial tears for 14 days
Outcomes
Primary Outcome Measures
Change in Baseline in Keratometry Values (K1 and K2)
The change in keratometry (K) values (K1 and K2) in all subjects
Change in Baseline in Axis of Astigmatism
The change in axis of astigmatism in all subjects
Secondary Outcome Measures
Change in Baseline Calculated Intraocular Lens Power
The change in intraocular lens power calculation in all subjects
Change in Keratometry Values (K1 and K2) in Ocular Surface Disease Subjects
The change in keratometry (K) values (K1 and K2) in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire
Change in Axis of Astigmatism in Ocular Surface Disease Subjects
The change in axis of corneal astigmatism in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire
Full Information
NCT ID
NCT04230720
First Posted
January 14, 2020
Last Updated
June 16, 2021
Sponsor
Weill Medical College of Cornell University
1. Study Identification
Unique Protocol Identification Number
NCT04230720
Brief Title
Effect of Artificial Tears on Biometry
Official Title
Impact of Lubrication With Artificial Tears on Biometry Measurements for Cataract Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Withdrawn
Why Stopped
Stopped due to COVID-19.
Study Start Date
April 2021 (Anticipated)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
The purpose of this study is to determine if measurements for cataract surgery are improved with use of additional lubrication with artificial tears. The research study is being done to optimize measurements and provide patients with the best visual outcomes after cataract surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
biometry measurement, artificial tear, cataract surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Artificial Tears
Arm Type
Experimental
Arm Description
One eye of each participant is randomized to receive Systane Complete artificial tears 4 times a day for 14 days
Arm Title
No Artificial Tears
Arm Type
No Intervention
Arm Description
One eye of each participant is randomized to receive no artificial tears for 14 days
Intervention Type
Drug
Intervention Name(s)
Systane Complete
Intervention Description
1 drop 4 times a day for 14 days
Primary Outcome Measure Information:
Title
Change in Baseline in Keratometry Values (K1 and K2)
Description
The change in keratometry (K) values (K1 and K2) in all subjects
Time Frame
Baseline, Day 14
Title
Change in Baseline in Axis of Astigmatism
Description
The change in axis of astigmatism in all subjects
Time Frame
Baseline, Day 14
Secondary Outcome Measure Information:
Title
Change in Baseline Calculated Intraocular Lens Power
Description
The change in intraocular lens power calculation in all subjects
Time Frame
Baseline, Day 14
Title
Change in Keratometry Values (K1 and K2) in Ocular Surface Disease Subjects
Description
The change in keratometry (K) values (K1 and K2) in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire
Time Frame
Baseline, Day 14
Title
Change in Axis of Astigmatism in Ocular Surface Disease Subjects
Description
The change in axis of corneal astigmatism in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire
Time Frame
Baseline, Day 14
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female ≥ 18 years of age
Documentation of bilateral age-related senile cataracts diagnosis
Exclusion Criteria:
Patients currently using regularly scheduled artificial tears. Patients with infrequent or irregular use of artificial tears may not be excluded from the study.
Patients using contact lenses.
Patients with any other surface pathology affecting corneal biometric measurements determined with slit-lamp examination or medical history.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ashley Brissette, MD
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Weill Cornell Ophthalmology
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effect of Artificial Tears on Biometry
We'll reach out to this number within 24 hrs